Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 5, 2025 • 4:00 PM ET

Date/Time Source News Release
06/03/2025 04:00 PM EDT Business Wire Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
06/02/2025 04:00 PM EDT Business Wire New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
05/22/2025 06:00 AM EDT Business Wire Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
05/14/2025 04:01 PM EDT Business Wire Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
05/06/2025 04:01 PM EDT Business Wire Personalis Reports First Quarter 2025 Financial Results
04/28/2025 05:00 PM EDT Business Wire Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
04/22/2025 04:01 PM EDT Business Wire Personalis to Announce First Quarter 2025 Financial Results
04/22/2025 06:00 AM EDT Business Wire Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
03/26/2025 04:01 PM EDT Business Wire Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
03/03/2025 06:00 AM EST Business Wire New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
Page

Additional News

As of July 5, 2025 • 4:00 PM ET

Date/Time Source News Release
07/04/2025 03:06 AM EDT SeekingAlpha Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook
07/03/2025 07:08 AM EDT Zacks Personalis (PSNL) Surges 14.2%: Is This an Indication of Further Gains?
06/17/2025 10:40 AM EDT Zacks Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?
06/13/2025 12:07 PM EDT Zacks Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach
06/08/2025 06:40 AM EDT SeekingAlpha Personalis: Ultra-Sensitive Tech, Ultra-Sensitive Risks
05/30/2025 09:05 AM EDT SeekingAlpha abrdn Healthcare Investors Q1 2025 Commentary
05/06/2025 08:41 PM EDT SeekingAlpha Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth
05/06/2025 08:41 PM EDT SeekingAlpha Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript
05/06/2025 05:55 PM EDT Zacks Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates
05/06/2025 04:06 PM EDT SeekingAlpha Personalis GAAP EPS of -$0.18 beats by $0.07, revenue of $20.6M beats by $3.19M
Page